Cargando…
Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions
Xanthohumol (XN) is a natural anticancer compound that inhibits the proliferation of oestrogen receptor-α (ERα)-positive breast cancer cells. However, the precise mechanism of the antitumour effects of XN on oestrogen (E2)-dependent cell growth, and especially its direct target molecule(s), remain(s...
Autores principales: | Yoshimaru, Tetsuro, Komatsu, Masato, Tashiro, Etsu, Imoto, Masaya, Osada, Hiroyuki, Miyoshi, Yasuo, Honda, Junko, Sasa, Mitsunori, Katagiri, Toyomasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258681/ https://www.ncbi.nlm.nih.gov/pubmed/25483453 http://dx.doi.org/10.1038/srep07355 |
Ejemplares similares
-
Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
por: Yoshimaru, Tetsuro, et al.
Publicado: (2015) -
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2017) -
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
por: Kim, Nam-Hee, et al.
Publicado: (2015) -
Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin‐containing protein inhibitor
por: Shikata, Yuki, et al.
Publicado: (2017) -
Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2013)